Physician profile
Shawn Birchenough
NPI 1518172972
$9,252.31
in general payments reported to CMS, 2019-2025
11 companies · $1,678 in 2025
The $1,678 reported for 2025 was more than what 81% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,225 · 2020: $922 · 2021: $827 · 2022: $2,071 · 2023: $1,435 · 2024: $1,096 · 2025: $1,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,882 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,882.29 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,675.60 | 2019-2022 | |
| Abbvie INC. | $2,401.42 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox, Alloderm |
| Rti Surgical, INC | $871.64 | 2022-2024 | |
| Mentor Worldwide LLC | $771.27 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $553.71 | 2019-2025 | Integra, Durasorb Monofilament Mesh, Omnigraft |
| Galderma Laboratories, L.P. | $338.09 | 2021-2025 | Dysport |
| Avita Medical Americas, LLC | $239.74 | 2024 | |
| Sanara Medtech INC. | $206.70 | 2025 | Celleraterx |
| Sientra, INC. | $124.49 | 2020-2022 | |
| Motiva USA, LLC | $52.51 | 2024-2025 | |
| Dexcom, INC. | $17.14 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Birchenough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.